Symbol
| FGF1
| contributors: mct/pgu - updated : 12-04-2016
|
HGNC name
| fibroblast growth factor 1 (acidic)
|
HGNC id
| 3665
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
results in diet-induced insulin resistance | |
Susceptibility
|
to intracranial aneurysm to Alzheimer disease(AD) to variation of systolic Blood pressure |
Variant & Polymorphism
SNP
| SNP at intron 4 increasing the risk of intracranial aneurysm |
|
promoter polymorphism (-1385 A/G) was significantly associated with AD risk |
|
SNP rs152524 was associated in a dose-dependent manner with systolic Blood pressure |
|
|
Candidate gene
Marker
Therapy target
| |
|
System | Type | Disorder | Pubmed |
cancer | | | |
mutant R50E suppressed tumor growth while WT FGF1 enhanced it using cancer cells that stably express WT FGF1 or R50E | cardiovascular | atheroma | | |
FGF1/MAPK14 inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction |
| | |
| Fgf1 is highly induced in adipose tissue in response to high-fat diet (HFD) and mice lacking Fgf1 develop an aggressive diabetic phenotype coupled to aberrant adipose expansion when challenged with HFD |